XBIOTECH INC's ticker is XBIT and the CUSIP is 98400H102. A total of 40 filers reported holding XBIOTECH INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $67,965 | -22.5% | 19,700 | -21.2% | 0.00% | – |
Q4 2022 | $87,750 | -18.8% | 25,000 | -15.8% | 0.00% | – |
Q3 2022 | $108,000 | -55.2% | 29,706 | -30.5% | 0.00% | -100.0% |
Q2 2022 | $241,000 | +3.9% | 42,772 | +59.6% | 0.00% | – |
Q1 2022 | $232,000 | -46.0% | 26,800 | -19.3% | 0.00% | -100.0% |
Q3 2021 | $430,000 | -21.5% | 33,200 | +0.3% | 0.00% | 0.0% |
Q2 2021 | $548,000 | -11.3% | 33,100 | -8.1% | 0.00% | 0.0% |
Q1 2021 | $618,000 | +4.7% | 36,000 | -4.5% | 0.00% | 0.0% |
Q4 2020 | $590,000 | -22.4% | 37,700 | -5.3% | 0.00% | -50.0% |
Q3 2020 | $760,000 | +83.6% | 39,800 | +31.8% | 0.00% | +100.0% |
Q2 2020 | $414,000 | +33.1% | 30,200 | +3.1% | 0.00% | 0.0% |
Q1 2020 | $311,000 | -33.5% | 29,300 | +16.7% | 0.00% | 0.0% |
Q4 2019 | $468,000 | +77.9% | 25,100 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $263,000 | +396.2% | 25,100 | +151.0% | 0.00% | – |
Q1 2018 | $53,000 | +35.9% | 10,000 | 0.0% | 0.00% | – |
Q4 2017 | $39,000 | -11.4% | 10,000 | 0.0% | 0.00% | – |
Q3 2017 | $44,000 | -6.4% | 10,000 | 0.0% | 0.00% | – |
Q2 2017 | $47,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 500,000 | $674,000 | 0.10% |
LGT Fund Management Co Ltd. | 10,000 | $111,000 | 0.03% |
Trexquant Investment LP | 20,648 | $230,000 | 0.01% |
Thomasville National Bank | 13,350 | $149,000 | 0.01% |
CAXTON ASSOCIATES LP | 10,309 | $115,000 | 0.01% |
Ergoteles LLC | 14,200 | $158,000 | 0.01% |
High Net Worth Advisory Group LLC | 1,500 | $17,000 | 0.01% |
Financial Connections Group, Inc. | 500 | $5,000 | 0.01% |
ALPS ADVISORS INC | 35,176 | $392,000 | 0.00% |
HRT FINANCIAL LP | 43,825 | $487,000 | 0.00% |